Toon Braeye

Ixelles, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.

Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.

Journal: Expert review of vaccines

Published: July 27, 2026

Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium.

Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: June 05, 2026

The impact of risk prioritization in COVID-19 vaccination in Belgium on hospital and intensive care unit admissions.

The impact of risk prioritization in COVID-19 vaccination in Belgium on hospital and intensive care unit admissions.

Journal: European journal of public health

Published: November 01, 2025

Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020 - January 2021, Belgium.

Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020 - January 2021, Belgium.

Journal: Archives of public health = Archives belges de sante publique

Published: August 20, 2025

Unmeasured confounding and misclassification in studies estimating vaccine effectiveness against hospitalisation and death using electronic health records (EHRs): an evaluation of a multi-country European retrospective cohort study.

Unmeasured confounding and misclassification in studies estimating vaccine effectiveness against hospitalisation and death using electronic health records (EHRs): an evaluation of a multi-country European retrospective cohort study.

Journal: BMC medical research methodology

Published: August 06, 2025

Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study.

Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study.

Journal: Vaccine

Published: July 16, 2025

Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity.

Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity.

Journal: PloS one

Published: June 27, 2025

Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study.

Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study.

Journal: Influenza and other respiratory viruses

Published: May 12, 2025

Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.

Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.

Journal: Epidemiology and infection

Published: March 16, 2025

Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023.

Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023.

Journal: Vaccine

Published: March 12, 2025

Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons.

Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons.

Journal: Nature communications

Published: December 17, 2024

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

Journal: Expert review of vaccines

Published: November 13, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026